Balaxi Pharmaceuticals
₹620.15
+20.5 (3.42%)
13 May, 2024 15:52 BSE:
NSE: BALAXIISIN: INE618N01014
Start SIP in Balaxi Pharmaceuticals
Start SIPBalaxi Pharmaceuticals Performance
Day Range
- Low 580
- High 634
52 Week Range
- Low 400
- High 686
- Open Price600
- Previous Close600
- Volume11895
Balaxi Pharmaceuticals Financials
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 13 | 17 | 25 | 30 |
| Operating Expenses Qtr Cr | 12 | 16 | 21 | 25 |
| Operating Profit Qtr Cr | 0 | 1 | 4 | 5 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 1 | 1 |
| Net Profit Qtr Cr | 0 | 1 | 3 | 4 |
Balaxi Pharmaceuticals Technicals
EMA & SMA
Current Price
₹620.15
+20.5 (3.42%)
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹586.68
- 50 Day
- ₹561.85
- 100 Day
- ₹532.66
- 200 Day
- ₹512.00
- 20 Day
- ₹586.97
- 50 Day
- ₹560.51
- 100 Day
- ₹517.74
- 200 Day
- ₹483.19
Balaxi Pharmaceuticals Resistance and Support
PIVOT
₹602.1
| Resistance | |
|---|---|
| First Resistance | 612.15 |
| Second Resistance | 624.65 |
| Third Resistance | 634.70 |
| RSI | 59.07 |
| MFI | 66.04 |
| MACD Single Line | 14.03 |
| MACD | 13.61 |
| Support | |
|---|---|
| First Resistance | 589.60 |
| Second Resistance | 579.55 |
| Third Resistance | 567.05 |
Balaxi Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 6,985 | 486,994 | 69.72 |
| Week | 5,429 | 348,555 | 64.2 |
| 1 Month | 6,797 | 486,144 | 71.52 |
| 6 Month | 12,736 | 673,095 | 52.85 |
Balaxi Pharmaceuticals Result Highlights
Balaxi Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Balaxi Pharmaceutica is involved in the business activities of Other specialized wholesale. Company’s Total Operating Revenue is Rs. 108.14 Cr. and Equity Capital is Rs. 10.18 Cr. for the Year ended 31/03/2023. Balaxi Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/09/1942 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L25191TG1942PLC121598 and registration number is 000045.| Market Cap | 644 |
| Sales | 85 |
| Shares in Float | 0.38 |
| No of funds | 4 |
| Yield |
| Book Value | 6.63 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | |
| Alpha | 0.01 |
| Beta | 0.56 |
Balaxi Pharmaceuticals
| Owner Name | Apr-24 | Mar-24 | Feb-24 | Dec-23 |
|---|---|---|---|---|
| Promoters | 66.36% | 66.86% | 67.8% | 71.22% |
| Foreign Portfolio Investors | 17.07% | 17.21% | 17.45% | 18.58% |
| Financial Institutions/ Banks | 0.02% | 0.02% | 0.02% | 0.03% |
| Individual Investors | 7.98% | 7.43% | 6.51% | 6.63% |
| Others | 8.57% | 8.48% | 8.22% | 3.54% |
Balaxi Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Ashish Maheshwari | Managing Director |
| Mrs. Minoshi Maheshwari | Non Executive Director |
| Mrs. Purnima Singh Kamble | Independent Director |
| Mr. M Srinivas Rao | Independent Director |
| Mr. Gandhi Gamji | Independent Director |
| Mr. Kunal M Bhakta | Independent Director |
Balaxi Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Balaxi Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-11-02 | Quarterly Results | |
| 2023-08-03 | Quarterly Results | |
| 2023-05-29 | Audited Results & Dividend | |
| 2023-02-01 | Quarterly Results | |
| 2022-11-05 | Quarterly Results |
Balaxi Pharmaceuticals FAQs
What is Share Price of Balaxi Pharmaceuticals ?
Balaxi Pharmaceuticals share price is ₹620 As on 13 May, 2024 | 15:38
What is the Market Cap of Balaxi Pharmaceuticals ?
The Market Cap of Balaxi Pharmaceuticals is ₹684.7 Cr As on 13 May, 2024 | 15:38
What is the P/E ratio of Balaxi Pharmaceuticals ?
The P/E ratio of Balaxi Pharmaceuticals is -131.2 As on 13 May, 2024 | 15:38
What is the PB ratio of Balaxi Pharmaceuticals ?
The PB ratio of Balaxi Pharmaceuticals is 3.7 As on 13 May, 2024 | 15:38